Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Sell
6,389
-130
-2% -$10.5K 0.24% 97
2026
Q1
$461K Sell
6,519
-42
-0.6% -$3.14K 0.22% 99
2025
Q4
$518K Sell
6,561
-142
-2% -$11.2K 0.25% 95
2025
Q3
$552K Sell
6,703
-624
-9% -$49.1K 0.27% 86
2025
Q2
$589K Sell
7,327
-416
-5% -$32.1K 0.3% 71
2025
Q1
$622K Buy
7,743
+631
+9% +$52.5K 0.35% 67
2024
Q4
$582K Sell
7,112
-384
-5% -$32K 0.58% 53
2024
Q3
$618K Buy
+7,496
New +$560K 0.61% 52

Other funds holding MET

CWC Advisors's MET Position: Q2 2026 in Review

CWC Advisors reduced its MetLife (MET) stake by 2% in Q2 2026, selling an estimated $10.5K and leaving 6,389 shares worth $541K. The position accounts for 0.24% of the portfolio, ranked #97.

CWC Advisors first reported a position in MET in Q3 2024 and has held it in 8 quarters since. The position peaked at $622K in Q1 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • CWC Advisors held 6,389 shares of MetLife worth $541K as of Q2 2026.
  • CWC Advisors sold 130 MetLife shares in Q2 2026, an estimated $10.5K.
  • MetLife made up 0.24% of CWC Advisors's portfolio in Q2 2026, its #97 holding.
  • CWC Advisors first reported a position in MetLife in Q3 2024 and has held it in 8 quarters since.
  • CWC Advisors's MetLife position peaked at $622K in Q1 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on CWC Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.